BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 30289300)

  • 1. MANAGEMENT OF THYROTOXICOSIS: PRECONCEPTION, PREGNANCY, AND THE POSTPARTUM PERIOD.
    Pearce EN
    Endocr Pract; 2019 Jan; 25(1):62-68. PubMed ID: 30289300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease.
    Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M
    Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational and Postpartum Complications in Patients with First Trimester Thyrotoxicosis: A Prospective Multicenter Cohort Study from Northeast China.
    Xu Y; Li C; Wang W; Yu X; Liu A; Shi Y; Xie X; Li J; Li Y; Shan Z; Teng W; Li Y
    Thyroid; 2023 Jun; 33(6):762-770. PubMed ID: 37051708
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum human chorionic gonadotropin levels and thyroid hormone levels in gestational transient thyrotoxicosis: Is the serum hCG level useful for differentiating between active Graves' disease and GTT?
    Yoshihara A; Noh JY; Mukasa K; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Watanabe N; Suzuki N; Kameda T; Sugino K; Ito K
    Endocr J; 2015; 62(6):557-60. PubMed ID: 25819223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SURVEY OF CLINICAL PRACTICE PATTERNS IN MANAGEMENT OF GRAVES DISEASE IN THE MIDDLE EAST AND NORTH AFRICA.
    Beshyah SA; Khalil AB; Sherif IH; Benbarka MM; Raza SA; Hussein W; Alzahrani AS; Chadli A
    Endocr Pract; 2017 Mar; 23(3):299-308. PubMed ID: 27967219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthyroidism: A Review.
    Lee SY; Pearce EN
    JAMA; 2023 Oct; 330(15):1472-1483. PubMed ID: 37847271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperthyroidism in Pregnancy: The Delicate Balance between Too Much or Too Little Antithyroid Drug.
    Gheorghiu ML; Bors RG; Gheorghisan-Galateanu AA; Pop AL; Cretoiu D; Varlas VN
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34442037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of post-partum thyrotoxicosis.
    Azizi F
    J Endocrinol Invest; 2006 Mar; 29(3):244-7. PubMed ID: 16682838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugs.
    Yoshihara A; Noh JY; Watanabe N; Iwaku K; Kobayashi S; Suzuki M; Ohye H; Matsumoto M; Kunii Y; Mukasa K; Ito K
    Clin Nucl Med; 2014 Apr; 39(4):326-9. PubMed ID: 24566408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease.
    Tamaki H; Itoh E; Kaneda T; Asahi K; Mitsuda N; Tanizawa O; Amino N
    Thyroid; 1993; 3(3):189-93. PubMed ID: 8257857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hyperfunction during pregnancy.
    Glinoer D
    Thyroid; 1998 Sep; 8(9):859-64. PubMed ID: 9777758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthyroidism and Pregnancy.
    Kobaly K; Mandel SJ
    Endocrinol Metab Clin North Am; 2019 Sep; 48(3):533-545. PubMed ID: 31345521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of gestational thyrotoxicosis in Asian women evaluated in the 8th to 14th weeks of pregnancy: correlations with total and free beta human chorionic gonadotrophin.
    Yeo CP; Khoo DH; Eng PH; Tan HK; Yo SL; Jacob E
    Clin Endocrinol (Oxf); 2001 Sep; 55(3):391-8. PubMed ID: 11589683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of Hyperthyroidism during the Preconception Phase, Pregnancy, and the Postpartum Period.
    Sarkar S; Bischoff LA
    Semin Reprod Med; 2016 Nov; 34(6):317-322. PubMed ID: 27741549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
    Amino N; Tanizawa O; Mori H; Iwatani Y; Yamada T; Kurachi K; Kumahara Y; Miyai K
    J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pitfalls in the assessment of gestational transient thyrotoxicosis.
    Iijima S
    Gynecol Endocrinol; 2020 Aug; 36(8):662-667. PubMed ID: 32301638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy for hyperthyroidism in pregnancy: safety issues for mother and fetus.
    Atkins P; Cohen SB; Phillips BJ
    Drug Saf; 2000 Sep; 23(3):229-44. PubMed ID: 11005705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves hyperthyroidism and pregnancy: a clinical update.
    Patil-Sisodia K; Mestman JH
    Endocr Pract; 2010; 16(1):118-29. PubMed ID: 19833580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of hyperthyroidism during pregnancy and lactation.
    Azizi F; Amouzegar A
    Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.